黑棘皮病
黑棘皮病是一種常見於糖尿病和肥胖患者的皮膚病。組織學上以表皮角質形成細胞和成纖維細胞增殖為特徵。臨床上，病變表現為深棕色增厚斑塊。頸部和腋下是最常見的受累部位。治療包括對潜在疾病的管理。局部使用維甲酸和鈣泊三醇也有一些有限的成功。其他治療方法包括雷射和手術切除。
Ref: https://www.researchgate.net/publication/49663976_...
黑棘皮病-多學科研證復康方案
- 藥物及其他醫療方案,請遵醫從醫生建議
- 飲食營養請依營養師指引
- 運動及或心理輔導,請參考各專家建議
- 為免錯誤診斷及漏診,請上傳最近一個月醫院的專業診斷報告,如證實是此症,則可參加試用期不如意退款計劃#。
可能適合的補充劑支援:
標準組合:
- 試用時期: 4星期
本產品並非根據《藥劑業及毒藥條例》或《中醫藥條例》注册。任何對其提出的索賠均不受此類登記評估的約束。本產品不用於診斷、治療或預防任何疾病。
If you have this disease, please follow your doctor's complete medical plan. You must consult the attending doctor before using the multidisciplinary rehabilitation plan. If your attending doctor does not recommend you to join the supplement conditioning combination, please do not use it. If you need to seek second opinion from other doctors, you can contact our online "Doctors Without Borders", or another professional doctor in your own city.
Acanthosis Nigricans
Acanthosis nigricans is a dermatologic condition commonly seen in diabetics and obese individuals. Histologically, it is characterized by the proliferation of epidermal keratinocytes and fibroblasts. Clinically, the lesions appear as dark-brown thickened plaques. The neck and the axillas are the most commonly affected sites. Treatment involves management of the underlying disorder. Topical tretinoin and calcipotriol have also been used with some limited success. Other treatment options include laser and surgical excision.
Ref: https://www.researchgate.net/publication/49663976_...
Multidisciplinary research and rehabilitation program for Acanthosis Nigricans
- Please follow the doctor's advice for drugs and other medical plans
- Please follow the guidance of nutritionist
- For sports or psychological counseling, please refer to the experts' suggestions
- In order to avoid misdiagnosis and missed diagnosis, please upload the professional diagnosis report of the hospital in the latest month. If it is confirmed to be this disease, you can participate in the
.#
Possible supplements supporting:
Standard combination:
- Mixed Inositol X2
- Sleeping Study X1
- Fibrosis Study X1
Trial period: 4 weeks
Products are not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.